Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $4.85 for the day, down -4.15% from the previous closing price of $5.06. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 0.8 million shares were traded. CADL stock price reached its highest trading level at $4.955 during the session, while it also had its lowest trading level at $4.7292.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.64. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.02.
On February 20, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
On February 19, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.Canaccord Genuity initiated its Buy rating on February 19, 2025, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 30 ’25 when WILLIAM GARRETT NICHOLS bought 3,593 shares for $4.90 per share.
Nichols William Garrett sold 45,316 shares of CADL for $396,995 on Mar 18 ’25. The Chief Medical Officer now owns 52,493 shares after completing the transaction at $8.76 per share. On Mar 18 ’25, another insider, Barone Francesca, who serves as the Chief Scientific Officer of the company, sold 32,146 shares for $8.76 each. As a result, the insider received 281,673 and left with 96,527 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 253018672 and an Enterprise Value of 172267552.
Stock Price History:
The Beta on a monthly basis for CADL is -0.91, which has changed by -0.23137873 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $3.79. The 50-Day Moving Average of the stock is -6.62%, while the 200-Day Moving Average is calculated to be -24.53%.
Shares Statistics:
CADL traded an average of 958.68K shares per day over the past three months and 1052590 shares per day over the past ten days. A total of 49.25M shares are outstanding, with a floating share count of 37.21M. Insiders hold about 30.22% of the company’s shares, while institutions hold 35.81% stake in the company. Shares short for CADL as of 1749772800 were 6259547 with a Short Ratio of 6.53, compared to 1747267200 on 6217963. Therefore, it implies a Short% of Shares Outstanding of 6259547 and a Short% of Float of 16.189999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
